A cause–effect relationship between Graves’ disease and the gut microbiome contributes to the thyroid–gut axis: A bidirectional two-sample Mendelian randomization study
Frontiers in Immunology · 2023
DOI: 10.3389/fimmu.2023.977587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, 2023. Verfasst von Jiamin Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Third Xiangya Hospital, Central South University, Hunan, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Graves Disease, Lactobacillales. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Background
An association between Graves’ disease (GD) and the gut microbiome has been identified, but the causal effect between them remains unclear.
Methods
Bidirectional two-sample Mendelian randomization (MR) analysis was used to detect the causal effect between GD and the gut microbiome. Gut microbiome data were derived from samples from a range of different ethnicities (18,340 samples) and data on GD were obtained from samples of Asian ethnicity (212,453 samples). Single nucleotide polymorphisms (SNPs) were selected as instrumental variables according to different criteria. They were used to evaluate the causal effect between exposures and outcomes through inverse-variance weighting (IVW), weighted median, weighted mode, MR-Egger, and simple mode methods. F -statistics and sensitivity analyses were performed to evaluate bias and reliability.
Results
In total, 1,560 instrumental variables were extracted from the gut microbiome data ( p < 1 × 10 5 ). The classes Deltaproteobacteria [odds ratio (OR) = 3.603] and Mollicutes , as well as the genera Ruminococcus torques group, Oxalobacter , and Ruminococcaceae UCG 011 were identified as risk factors for GD. The family Peptococcaceae and the genus Anaerostipes (OR = 0.489) were protective factors for GD. In addition, 13 instrumental variables were extracted from GD ( p < 1 × 10 –8 ), causing one family and eight genera to be regulated. The genus Clostridium innocuum group ( p = 0.024, OR = 0.918) and Anaerofilum ( p = 0.049, OR = 1.584) had the greatest probability of being regulated. Significant bias, heterogeneity, and horizontal pleiotropy were not detected.
Conclusion
A causal effect relationship exists between GD and the gut microbiome, demonstrating regulatory activity and interactions, and thus providing evidence supporting the involvement of a thyroid–gut axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, The Third Xiangya Hospital, Central South University, Hunan, China.
- Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Hunan, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Cao, J., Wang, N., Luo, Y., Ma, C., Chen, Z., Chenzhao, C., Zhang, F., Qi, X., & Xiong, W. (2023). A cause–effect relationship between Graves’ disease and the gut microbiome contributes to the thyroid–gut axis: A bidirectional two-sample Mendelian randomization study. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.977587
Vancouver
Cao J, Wang N, Luo Y, Ma C, Chen Z, Chenzhao C, et al. A cause–effect relationship between Graves’ disease and the gut microbiome contributes to the thyroid–gut axis: A bidirectional two-sample Mendelian randomization study. Frontiers in Immunology. 2023. doi:10.3389/fimmu.2023.977587
BibTeX
@article{Cao2023,
author = {Cao, Jiamin and Wang, Nuo and Luo, Yong and Ma, Chen and Chen, Zhuokun and Chenzhao, Changci and Zhang, Feng and Qi, Xin and Xiong, Wei},
title = {A cause–effect relationship between Graves’ disease and the gut microbiome contributes to the thyroid–gut axis: A bidirectional two-sample Mendelian randomization study},
journal = {Frontiers in Immunology},
year = {2023},
doi = {10.3389/fimmu.2023.977587}
}
EUVIMED